Optimizing IRT For Clinical Supply Management

By Laurel Ferenchick, Senior Clinical Supply Manager, PCI Pharma Services, and Marc Lisi, Co-Founder and Director of Business Development, Suvoda

Laurel Ferenchick, PCI’s Senior Clinical Supply Manager, and Marc Lisi, Suvoda’s Co-founder and Director of Business Development, recently spoke on the various supply capabilities within IRT.

Laurel and Mark explained what to ask for and who to involve when developing a list of needs for an IRT system to optimize the clinical supply chain. They described ways that flexibility is important to functionality, such as drug resupply settings, initial shipment triggering, and direct-to-patient logistics. And when figuring out what questions to ask in optimizing IRT for clinical supply, they suggested scenario planning as it relates to study protocols, priming professional networks for information on solutions, and being up front with IRT vendors on needs and nice-to-haves.